Interface, Inc. Faces Valuation Shift Amid Strong Financial Performance and Market Gains

Oct 23 2025 03:36 PM IST
share
Share Via
Interface, Inc., a small-cap company in the Building Products sector, has recently experienced a change in its valuation grade. Key financial metrics reveal a P/E ratio of 14 and a price-to-book value of 2.30, indicating a complex financial landscape despite positive performance in operating cash flow and market returns.
Interface, Inc. Faces Valuation Shift Amid Strong Financial Performance and Market Gains
Interface, Inc., a small-cap player in the Building Products industry, has recently undergone an adjustment in its evaluation. The revision in its score reflects a shift in the valuation grade, which has transitioned from a previously favorable position to a more expensive classification.
Key financial metrics indicate that the company maintains a P/E ratio of 14, alongside a price-to-book value of 2.30. The enterprise value to EBITDA stands at 7.99, while the PEG ratio is noted at 0.37. These figures suggest a complex financial landscape for Interface, Inc., particularly when considering its return on capital employed (ROCE) of 17.86% and return on equity (ROE) of 16.32%. Despite the recent changes, the company has demonstrated positive financial performance in the quarter ending June 2025, with operating cash flow reaching USD 156.14 million and a notably low debt-equity ratio of 48.05%. Additionally, the stock has shown strong market performance, generating a return of 41.78% over the past year, while also outperforming the S&P 500 across various time frames. For more insights on Interface, Inc. and its financial trend performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
Saboo Sodium Chloro Ltd is Rated Sell
51 minutes ago
share
Share Via
Jenburkt Pharmaceuticals Ltd. is Rated Sell
51 minutes ago
share
Share Via
iStreet Network Ltd is Rated Sell
51 minutes ago
share
Share Via
Emmbi Industries Ltd is Rated Sell
51 minutes ago
share
Share Via
Cohance Lifesciences Ltd is Rated Sell
51 minutes ago
share
Share Via
Vivo Bio Tech Ltd. is Rated Strong Sell
51 minutes ago
share
Share Via